Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Schizophrenia Research
|
October 23, 2009
Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels
Francisco J Diaz, Alexander Meary, Maria J Arranz, et al.
Schizophrenia Research
|
November 23, 2007
Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels
Jose de Leon, Juan Carlos Correa, Gualberto Ruaño, et al.
Journal of the American Academy of Nurse Practitioners
|
September 9, 2011
Guidance of pharmacotherapy in a complex psychiatric case by CYP450 DNA typing
Joan Landino, Jane Buckley, John M Roy, et al.
Biomarkers in Medicine
|
August 25, 2011
Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes
David Villagra, John Goethe, Harold I Schwartz, et al.
Connecticut Medicine
|
September 4, 2008
Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report
Anthony LaSala, Bruce Bower, Andreas Windemuth, et al.
Nutrition & Metabolism
|
February 8, 2008
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
Richard L Seip, Jeff S Volek, Andreas Windemuth, et al.
Schizophrenia Research
|
March 10, 2007
A clinical study of the association of antipsychotics with hyperlipidemia
Jose de Leon, Margaret T Susce, Maria Johnson, et al.
Pharmacogenomics
|
November 22, 2005
Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis
Gualberto Ruaño, Paul D Thompson, Andreas Windemuth, et al.
Personalized Medicine
|
May 24, 2018
Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital
Gualberto Ruaño, David Villagra, Umme Salma Rahim, et al.
Biomarkers in Medicine
|
August 25, 2011
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients
Gualberto Ruaño, David Villagra, Bonnie Szarek, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Schizophrenia Research
|
October 23, 2009
Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels
Francisco J Diaz, Alexander Meary, Maria J Arranz, et al.
Schizophrenia Research
|
November 23, 2007
Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels
Jose de Leon, Juan Carlos Correa, Gualberto Ruaño, et al.
Journal of the American Academy of Nurse Practitioners
|
September 9, 2011
Guidance of pharmacotherapy in a complex psychiatric case by CYP450 DNA typing
Joan Landino, Jane Buckley, John M Roy, et al.
Biomarkers in Medicine
|
August 25, 2011
Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes
David Villagra, John Goethe, Harold I Schwartz, et al.
Connecticut Medicine
|
September 4, 2008
Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report
Anthony LaSala, Bruce Bower, Andreas Windemuth, et al.
Nutrition & Metabolism
|
February 8, 2008
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
Richard L Seip, Jeff S Volek, Andreas Windemuth, et al.
Schizophrenia Research
|
March 10, 2007
A clinical study of the association of antipsychotics with hyperlipidemia
Jose de Leon, Margaret T Susce, Maria Johnson, et al.
Pharmacogenomics
|
November 22, 2005
Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis
Gualberto Ruaño, Paul D Thompson, Andreas Windemuth, et al.
Personalized Medicine
|
May 24, 2018
Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital
Gualberto Ruaño, David Villagra, Umme Salma Rahim, et al.
Biomarkers in Medicine
|
August 25, 2011
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients
Gualberto Ruaño, David Villagra, Bonnie Szarek, et al.
Page
of 5